Rachael Nimmo

605 total citations
16 papers, 430 citations indexed

About

Rachael Nimmo is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Rachael Nimmo has authored 16 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Hematology and 4 papers in Cancer Research. Recurrent topics in Rachael Nimmo's work include Acute Myeloid Leukemia Research (4 papers), Genetics, Aging, and Longevity in Model Organisms (3 papers) and MicroRNA in disease regulation (3 papers). Rachael Nimmo is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Genetics, Aging, and Longevity in Model Organisms (3 papers) and MicroRNA in disease regulation (3 papers). Rachael Nimmo collaborates with scholars based in United Kingdom, Japan and United States. Rachael Nimmo's co-authors include Frank J. Slack, Alison Woollard, Tariq Enver, Gillian May, Adam Antebi, Elitza Deltcheva, Anna Bigas, Cristina Ruiz‐Herguido, Roger Patient and Shamit Soneji and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Development.

In The Last Decade

Rachael Nimmo

16 papers receiving 427 citations

Peers

Countries citing papers authored by Rachael Nimmo

Since Specialization

Citations

This map shows the geographic impact of Rachael Nimmo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachael Nimmo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachael Nimmo more than expected).

Fields of papers citing papers by Rachael Nimmo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachael Nimmo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachael Nimmo. The network helps show where Rachael Nimmo may publish in the future.

Co-authorship network of co-authors of Rachael Nimmo

This figure shows the co-authorship network connecting the top 25 collaborators of Rachael Nimmo. A scholar is included among the top collaborators of Rachael Nimmo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachael Nimmo. Rachael Nimmo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Efficient in vivo generation of CAR T cells using a retargeted fourth-generation lentiviral vector 2025 ·Molecular Therapy ·(unknown), (unknown), Alun R. Barnard, Lynsey M. Whilding, (unknown), Zara Hannoun, Jack L. Lewis, Gayathri Devarajan, Sharifah Iqball, Edward A. Burton, Sara Ferluga, Daniel M. Jones, Bruce Alberts, J. J. Wright, (unknown), Deirdre O’Connor, Renuka Rao, Kyriacos Mitrophanous, Yatish Lad, Rachael Nimmo	4
2	Targeting Tumor Antigen 5T4 Using CAR T Cells for the Treatment of Acute Myeloid Leukemia 2024 ·Molecular Cancer Therapeutics ·(unknown), Daniel G. Blount, Naeem Khan, (unknown), Laura Moyce, Mark T. Drayson, Jenny Down, Michelle A. Lawson, (unknown), Rachael Nimmo, Yatish Lad, Bernard Souberbielle, Kyriacos Mitrophanous, Anna Ettorre	2
3	A gain‐of‐function mutation in microRNA 142 is sufficient to cause the development of T‐cell leukemia in mice 2023 ·Cancer Science ·(unknown), Kimi Araki, Jie Bai, (unknown), (unknown), Kumiko Yoshinobu, Shingo Usuki, Rachael Nimmo, Tadashi Kaname, Masaharu Yoshihara, Satoru Takahashi, Goro Sashida, Masatake Araki	2
4	Regulome analysis in B-acute lymphoblastic leukemia exposes Core Binding Factor addiction as a therapeutic vulnerability 2022 ·Nature Communications ·Jason Wray, Elitza Deltcheva, Charlotta Böiers, Simon Richardson, (unknown), John Brown, Sladjana Gagrica, Yanping Guo, Anuradha Illendula, Joost H.A. Martens, Hendrik G. Stunnenberg, John H. Bushweller, Rachael Nimmo, Tariq Enver	6
5	Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors 2022 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), Rachael Nimmo, Yatish Lad, Stephen C. Hyde, (unknown), Deborah R. Gill	6
6	MicroRNA-142 Critically Regulates Group 2 Innate Lymphoid Cell Homeostasis and Function 2021 ·The Journal of Immunology ·Luke B. Roberts, Geraldine M. Jowett, Emily Read, (unknown), (unknown), Murray E. Selkirk, Ian Jackson, Umar Niazi, (unknown), Masatake Araki, Kimi Araki, Jagath Kasturiarachchi, Chela James, Tariq Enver, Rachael Nimmo, (unknown), Jane K. Howard, Joana F. Neves, Graham M. Lord	10
7	Author Correction: Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes 2021 ·Scientific Reports ·(unknown), Jagath Kasturiarachchi, (unknown), Yanping Guo, Elitza Deltcheva, CP James, John Brown, G. May, (unknown), Ian Jackson, Jane K. Howard, Essam Ghazaly, Simon P. Brooks, Asim Khwaja, Masatake Araki, Kimi Araki, D C Linch, Graham M. Lord, Tariq Enver, Rachael Nimmo	1
8	Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes 2020 ·Scientific Reports ·(unknown), Jagath Kasturiarachchi, (unknown), Yanping Guo, Elitza Deltcheva, Chela James, John Brown, G. May, (unknown), Ian Jackson, Jane K. Howard, Essam Ghazaly, Simon P. Brooks, Asim Khwaja, Masatake Araki, Kimi Araki, David C. Linch, Graham M. Lord, Tariq Enver, Rachael Nimmo	10
9	RUNX transcription factors at the interface of stem cells and cancer 2017 ·Biochemical Journal ·Elitza Deltcheva, Rachael Nimmo	33
10	Primed and ready: understanding lineage commitment through single cell analysis 2015 ·Trends in Cell Biology ·Rachael Nimmo, Gillian May, Tariq Enver	56
11	miR-142-3p Controls the Specification of Definitive Hemangioblasts during Ontogeny 2013 ·Developmental Cell ·Rachael Nimmo, Aldo Ciau‐Uitz, Cristina Ruiz‐Herguido, Shamit Soneji, Anna Bigas, Roger Patient, Tariq Enver	59
12	An elegant miRror: microRNAs in stem cells, developmental timing and cancer 2009 ·Chromosoma ·Rachael Nimmo, Frank J. Slack	105
13	Worming out the biology of Runx 2007 ·Developmental Biology ·Rachael Nimmo, Alison Woollard	30
14	TheC. elegansCBFβ homologue BRO-1 interacts with the Runx factor, RNT-1, to promote stem cell proliferation and self-renewal 2007 ·Development ·Hiroshi Kagoshima, Rachael Nimmo, (unknown), Junko Tanaka, Yoshihiro Miwa, Shohei Mitani, Yuji Kohara, Alison Woollard	42
15	mab-2encodes RNT-1, aC. elegansRunx homologue essential for controlling cell proliferation in a stem cell-like developmental lineage 2005 ·Development ·Rachael Nimmo, Adam Antebi, Alison Woollard	55
16	Widespread organisation of C. elegans genes into operons: Fact or function? 2002 ·BioEssays ·Rachael Nimmo, Alison Woollard	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact